Can you work or drive while taking Levodopa + benserazide?

Levodopa + benserazide is a CNS depressant that may cause sedation, drowsiness, and impaired coordination. It can affect driving ability and work capacity, particularly in safety-sensitive roles. Work capacity should be assessed on a case-by-case basis.

What should a case manager know about Levodopa + benserazide?

Case managers should note that Levodopa + benserazide is Low risk. It is a CNS depressant that may affect work capacity. Always check for drug interactions with other medications on the claim.

Other | Low Risk

Levodopa + benserazide (Madopar Rapid 62.5)

Q: What risk level is Levodopa + benserazide for workers compensation claims?

Levodopa + benserazide is classified as Low risk (2 risk points) by AllMeds. Dopaminergic agent causing dyskinesias, hallucinations and potential orthostatic hypotension affecting workplace safety.

Q: What schedule is Levodopa + benserazide in Australia?

Levodopa + benserazide is classified as S4 under the Therapeutic Goods Administration (TGA) in Australia.

What to know about Levodopa + benserazide — also sold as Madopar Rapid 62.5, Madopar 125, Madopar 62.5, Madopar, Madopar HBS and 1 more: uses, side effects, interactions, and safety considerations for people taking it or caring for someone who is.

Levodopa + benserazide (brand names: Madopar Rapid 62.5, Madopar 125, Madopar 62.5, Madopar, Madopar HBS and 1 more) is classified as Low risk (2 risk points) by AllMeds. It is a S4 medication under the TGA in Australia. Dopaminergic agent causing dyskinesias, hallucinations and potential orthostatic hypotension affecting workplace safety.

Key Takeaways

TGA Schedule: S4 in Australia
Risk level: Low (2 points)
CNS depressant: May cause sedation, impair driving, and affect work capacity
PBS listed: Subsidised under the Australian Pharmaceutical Benefits Scheme

Scheduling and Classification

Jurisdiction	Classification	Status
Australia (TGA)	S4	PBS listed

Risk Profile

Risk Level Low

Risk Points 2

CNS Depressant Yes

Respiratory Risk No

Dopaminergic agent causing dyskinesias, hallucinations and potential orthostatic hypotension affecting workplace safety.

How Levodopa + benserazide is regulated

Levodopa + benserazide is overseen by medicines regulators in each country. The rules below explain how it's scheduled, what oversight applies, and what to discuss with your doctor or pharmacist before starting, changing, or stopping this medication.

Work capacity impact: As a CNS depressant, Levodopa + benserazide may impair driving, operating machinery, and cognitive function. Work capacity certificates should reflect any medication-related restrictions.

Australia TGA / PBS / State Schemes

Classified as S4 under the Therapeutic Goods Administration (TGA).

Listed on the Pharmaceutical Benefits Scheme (PBS) for subsidised prescribing.

Check this medication against your full medication list

Run a full risk assessment including Levodopa + benserazide interactions and compliance checks.

Allmeds AI Pharmacist scans interactions, schedules, and risk flags across your entire medication profile in minutes. Free for individuals; team plans for case managers, insurers, and schemes.

Try it free → Talk to Sales →

Important: This page is general health information, not personal medical advice. If you have questions about your medication — including starting it, stopping it, changing the dose, or combining it with something else — speak with your doctor or pharmacist. For an emergency or suspected overdose, call your local emergency number or poison information service immediately. Information is drawn from regulator and clinical guideline sources (TGA, FDA, MHRA, NICE, PBS, CDC); see our methodology for details.